MOBI logo

MOBIA MEDICAL INC

MOBINASDAQ
πŸ† #3079 by market capEarnings Nov 5US Equity
$11.27β–Ό $0.52 (βˆ’4.41%)
πŸŒ™ After hours$11.27β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track MOBI
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 4.4%
7dβ–² 6.3%
14dβ–² 35.1%
30dβ–² 24.7%
ytdβ€”
1yβ€”
🏦Market Cap
$375M
Small Cap
πŸ“ˆRevenue Growth (YoY)
0.0%
Slowing
πŸ“ŠGross Margin
82.8%
High
πŸ’΅FCF Margin
-136.8%
Thin
βš–οΈP/S Ratio
14.7x
Expensive
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$11.06 – $11.92
52-Week Range
$8.03 – $15.29
Volume (shares)
132,647
Avg Volume (shares)
β€”
Shares Outstanding
33.3M
Next Earnings
2026-11-05

Fundamentals Snapshot

Annual Revenue
$32M
Last Q Revenue
$14M
P/E Ratio
-6.9
P/S Ratio
14.7x
EPS (TTM)
$-2.03
Dividend Yield
0.00%
MOBI logo

MOBIA MEDICAL INC

MOBI
Financial Trends

Financial history unavailable.

StockOtter Β· stockotter.space

About MOBIA MEDICAL INC

Mobia Medical, Inc. functions as a commercial-level medical device enterprise, concentrating on developing therapeutic solutions for individuals recovering from strokes who experience motor impairments. The company was established on March 5, 2007, by its founders Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini, and it maintains its corporate headquarters in Austin, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
10 analysts
Strong Buy5
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

GlobeNewsWireΒ·14d ago

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026

AUSTIN, Texas, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the

Defense WorldΒ·24d ago

Mobia Medical, Inc. (NASDAQ:MOBI) Stock Now Rated β€œModerate Buy” by Sell-Side Analysts

Mobia Medical, Inc. (NASDAQ: MOBI - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rate

GlobeNewsWireΒ·Aug 28

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines

AUSTIN, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that imp

Seeking AlphaΒ·Aug 11

Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript

Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript

MarketBeatΒ·Aug 11

Mobia Medical Q2 Earnings Call Highlights

Mobia Medical NASDAQ: MOBI reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing s

GlobeNewsWireΒ·Aug 11

Mobia Medical Reports Second Quarter 2026 Financial Results

AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported financial